The research utility of GW-501516 Cardarine lies in its ability to mimic the physiological effects of exercise at a molecular level through the activation of the PPAR$\delta$ pathway. Key Areas of Laboratory Investigation: Enhanced Fatty Acid Oxidation: GW-501516 activates PPAR$\delta$, which upregulates the expression of genes involved in the transport and oxidation of fatty acids. Researchers observe how this leads to increased lipid catabolism and a “glucose-sparing” effect. Mitochondrial Biogenesis: Laboratory studies investigate GW-501516 Cardarine’s role in increasing mitochondrial density in skeletal muscle. By activating the PGC-1$\alpha$ pathway, it is used to model improvements in aerobic capacity and oxidative phosphorylation. Lipid Profile Regulation: Research indicates that GW-501516 Cardarine modulation can lead to increased HDL (high-density lipoprotein) levels and decreased VLDL (very-low-density lipoprotein) and triglycerides, making it a subject of interest in cardiovascular health and metabolic syndrome studies. Anti-Inflammatory Properties: Beyond metabolism, GW-501516 Cardarine is studied for its ability to suppress pro-inflammatory signaling in vascular endothelial cells, providing a model for investigating the prevention of atherosclerosis. Chemical & Technical Specifications Property Specification Chemical Name {4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid Molecular Formula $C_{21}H_{18}F_{3}NO_{3}S_{2}$ Molecular Weight 453.5 g/mol Purity ≥99% (HPLC Verified) CAS Number 317318-70-0 Form Fine White Powder / Liquid Suspension
